Importance of attributes and willingness to pay for lipid-lowering agents in patients with hypercholesterolemia in Hong Kong: a discrete choice experiment
Grant Data
Project Title
Importance of attributes and willingness to pay for lipid-lowering agents in patients with hypercholesterolemia in Hong Kong: a discrete choice experiment
Principal Investigator
Professor Chan, Esther Wai Yin
(Principal Investigator (PI))
Co-Investigator(s)
Dr. YE Xuxiao
(Co-principal investigator)
Professor Tse Hung Fat
(Co-principal investigator)
Professor Wong William Chi Wai
(Co-principal investigator)
Yan Ping Yen Bryan
(Co-Investigator)
Wong Chi Sang Martin
(Co-Investigator)
Professor Li Xue
(Co-principal investigator)
Dr Wong Carlos King Ho
(Co-principal investigator)
Mr Blais Joseph
(Co-principal investigator)
Duration
24
Start Date
2023-07-03
Amount
1122040
Conference Title
Importance of attributes and willingness to pay for lipid-lowering agents in patients with hypercholesterolemia in Hong Kong: a discrete choice experiment
Keywords
lipid-lowering agents, inclisiran, PCSK9 inhibitors, evolocumab, alirocumab
Discipline
Public Health
Panel
Biology and Medicine (M)
HKU Project Code
20211921
Grant Type
Health and Medical Research Fund 2021
Funding Year
2022
Status
On-going
Objectives
Health systems and patients have several choices of lipid-lowering agents with different characteristics. This study aims to investigate the importance of attributes, and the willingness to pay for lipid-lowering agents in patients with hypercholesterolemia in Hong Kong.